Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - vildagliptinum - vildagliptin zentiva 50 mg tabletten - vildagliptinum 50 mg, lactosum 136 mg, carboxymethylamylum natricum a corresp. natrium 0.336 - 0.504 mg, magnesii stearas, pro compresso. - il diabete mellito di tipo 2 - synthetika

Unione Europea - italiano - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabete mellito, tipo 2 - farmaci usati nel diabete - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 per i dati disponibili su diverse combinazioni).

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

sandoz s.p.a. - vildagliptin - vildagliptin

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

krka d.d. novo mesto - vildagliptin - vildagliptin

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

aurobindo pharma (italia) s.r.l. - vildagliptin - vildagliptin

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

zentiva italia s.r.l. - vildagliptin - vildagliptin

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

teva b.v. - vildagliptin - vildagliptin

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

intas third party sales 2005, s.l. - vildagliptin - vildagliptin

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - vildagliptinum - compresse - vildagliptinum 50.0 mg, cellulosum microcristallinum, lactosum 47.82 mg, carboxymethylamylum natricum a corresp. natrium max. 0.3 mg, magnesii stearas, pro compresso. - farmaco antidiabetico orale - synthetika

Unione Europea - italiano - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformina cloridrato - diabete mellito, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 per i dati disponibili su diverse combinazioni).